Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Pharmacokinetic data support use of oral deferasirox in transfusional hemosiderosis

June 27, 2003

Pfizer researchers describe new neuronal nAChR ligands for nicotine addiction

June 23, 2003

Second phase IIa study for TA-CD in cocaine dependence reports findings

June 19, 2003

Agents for iron overload therapy disclosed by Novartis researchers

June 3, 2003

Nippon Shinyaku acquires Japanese rights to acamprosate

May 28, 2003

Rat study suggests potential of topiramate in treating nicotine addiction

May 8, 2003

Ilomastat successful in treating exposure to mustard gas

April 24, 2003

Elite develops opioid antagonist product to minimize abuse potential

April 17, 2003

TA-CD enters phase IIa cocaine administration study

April 16, 2003

Evidence for potential of SB-277011-A in drug dependence and psychosis

April 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...